Flavonoid metabolites reduce tumor necrosis factor-α secretion to a greater extent than their precursor compounds in human THP-1 monocytes

Molecular Nutrition and Food Research

Volumn 59, Issue 6, 2015, Pages 1143-1154

  di Gesso, Jessica L ^a,b   Kerr, Jason S ^a,b   Zhang, Qingzhi ^c   Raheem, Saki ^c   Yalamanchili, Sai Krishna ^a   O'Hagan, David ^c   Kay, Colin D ^b   O'Connell, Maria A ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Cytokine; Inflammation; Metabolism; Phase 2 conjugates; Polyphenol

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; 4-HYDROXYBENZOIC ACID; FLAVONOID; HYDROXYBENZOIC ACID DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTOCATECHUIC ACID; TUMOR NECROSIS FACTOR ALPHA;

CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MONOCYTE; SECRETION (PROCESS);

CELL LINE; CELL SURVIVAL; FLAVONOIDS; HUMANS; HYDROXYBENZOATES; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PARABENS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930177527     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400799     Document Type: Article

References (60)

1. Perez-Jimenez, J., Neveu, V., Vos, F., Scalbert, A., Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J. Agr. Food Chem. 2010, 58, 4959-4969.
2. Manach, C., Scalbert, A., Morand, C., Remesy, C. et al., Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
3. Cassidy, A., O'Reilly, E. J., Kay, C., Sampson, L. et al., Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 2011, 93, 338-347.
4. Hamaguchi, T., Ono, K., Murase, A., Yamada, M., Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. Am. J. Pathol. 2009, 175, 2557-2565.
5. Spatafora, C., Tringali, C., Natural-derived polyphenols as potential anticancer agents. Anticancer Agents Med. Chem. 2012, 12, 902-918.
6. Candore, G., Caruso, C., Jirillo, E., Magrone, T. et al., Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr. Pharm. Des. 2010, 16, 584-596.
7. Wu, J. J., Poon, K. Y., Channual, J. C., Shen, A. Y., Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis. Arch. Dermatol. 2012, 148, 1244-1250.
8. Abbate, A., VanTassell, B. W., Biondi-Zoccai, G. G., Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. BioDrugs 2012, 26, 217-233.
9. Egert, S., Boesch-Saadatmandi, C., Wolffram, S., Rimbach, G. et al., Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J. Nutr. 2010, 140, 278-284.
10. Yuan, L., Zhou, X., Li, D., Ma, W. et al., Pattern recognition receptors involved in the inflammatory attenuating effects of soybean isoflavone in beta-amyloid peptides 1-42 treated rats. Neurosci. Lett. 2012, 506, 266-270.
11. Ha, S. K., Park, H. Y., Eom, H., Kim, Y. et al., Narirutin fraction from citrus peels attenuates LPS-stimulated inflammatory response through inhibition of NF-kappaB and MAPKs activation. Food Chem. Toxicol. 2012, 50, 3498-3504.
12. Essafi-Benkhadir, K., Refai, A., Riahi, I., Fattouch, S. et al., Quince (Cydonia oblonga Miller) peel polyphenols modulate LPS-induced inflammation in human THP-1-derived macrophages through NF-kappaB, p38MAPK and Akt inhibition. Biochem. Biophys. Res. Commun. 2012, 418, 180-185.
13. Park, H. J., Jung, U. J., Cho, S. J., Jung, H. K. et al., Citrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db mice. J. Nutr. Biochem. 2013, 24, 419-427.
14. Lai, W. W., Hsu, S. C., Chueh, F. S., Chen, Y. Y. et al., Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-kappaB and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res. 2013, 33, 1941-1950.
15. Speciale, A., Canali, R., Chirafisi, J., Saija, A. et al., Cyanidin-3-O-glucoside protection against TNF-alpha-induced endothelial dysfunction: involvement of nuclear factor-kappaB signaling. J. Agr. Food Chem. 2010, 58, 12048-12054.
16. Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P., Tognolini, M. et al., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2013, 18, 1818-1892.
17. deFerrars, R. M., Czank, C., Zhang, Q., Botting, N. P. et al., The pharmacokinetics of anthocyanins and their metabolites in humans. Brit. J. Pharmacol. 2014, 171, 3268-3282.
18. Crozier, A., Absorption, metabolism, and excretion of (-)-epicatechin in humans: an evaluation of recent findings. Am. J. Clin. Nutr. 2013, 98, 861-862.
19. Czank, C., Cassidy, A., Zhang, Q., Morrison, D. J. et al., Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. Am. J. Clin. Nutr. 2013, 97, 995-1003.
20. Manach, C., Williamson, G., Morand, C., Scalbert, A. et al., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
21. Ogborne, R. M., Rushworth, S. A., O'Connell, M. A., Epigallocatechin activates haem oxygenase-1 expression via protein kinase Cdelta and Nrf2. Biochem. Biophys. Res. Commun. 2008, 373, 584-588.
22. Urpi-Sarda, M., Monagas, M., Khan, N., Llorach, R. et al., Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258-7267.
23. Rios, L. Y., Gonthier, M. P., Remesy, C., Mila, I. et al., Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr. 2003, 77, 912-918.
24. Zhang, Q., Raheem, K. S., Botting, N. P., Slawin, A. M. Z. et al., Flavonoid metabolism: the synthesis of phenolic glucuronides and sulfates as candidate metabolites for bioactivity studies of dietary flavonoids. Tetrahedron 2012, 68, 4194-4201.
25. Steel, R., Cowan, J., Payerne, E., O'Connell, M. A. et al., Anti-inflammatory effect of a cell-penetrating peptide targeting the Nrf2/Keap1 interaction. ACS Med. Chem. Lett. 2012, 3, 407-410.
26. Wang, X. J., Hayes, J. D., Henderson, C. J., Wolf, C. R., Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha. Proc. Natl. Acad. Sci. US A 2007, 104, 19589-19594.
27. Speciale, A., Chirafisi, J., Saija, A., Cimino, F., Nutritional antioxidants and adaptive cell responses: an update. Curr. Mol. Med. 2011, 11, 770-789.
28. Bhardwaj, P., Khanna, D., Green tea catechins: defensive role in cardiovascular disorders. Chin. J. Nat. Med. 2013, 11, 345-353.
29. Latif, R., Health benefits of cocoa. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 669-674.
30. Gonzalez-Gallego, J., Garcia-Mediavilla, M. V., Sanchez-Campos, S., Tunon, M. J., Fruit polyphenols, immunity and inflammation. Brit. J. Nutr. 2010, 104(Suppl 3), S15-S27.
31. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38-50.
32. Rodriguez-Mateos, A., Pino-Garcia, R. D., George, T. W., Vidal-Diez, A. et al., Impact of processing on the bioavailability and vascular effects of blueberry (poly)phenols. Mol. Nutr. Food Res. 2014, 58, 1952-1961.
33. Zamora-Ros, R., Andres-Lacueva, C., Lamuela-Raventos, R. M., Berenguer, T. et al., Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J. Am. Diet. Assoc. 2010, 110, 390-398.
34. Chun, O. K., Chung, S. J., Song, W. O., Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007, 137, 1244-1252.
35. Mullie, P., Clarys, P., Deriemaeker, P., Hebbelinck, M., Estimation of daily human intake of food flavonoids. Plant Food. Hum. Nutr. 2007, 62, 93-98.
36. Vitaglione, P., Donnarumma, G., Napolitano, A., Galvano, F. et al., Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr. 2007, 137, 2043-2048.
37. Schär, M. Y., Curtis, P. J., Hazim, S. Ostertag, L. M. et al., Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease. Am. J. Clin. Nutr. 2015. doi: 10.3945/ajcn.114.104364.
38. Hernandez, L., Afonso, D., Rodriguez, E. M., Diaz, C., Phenolic compounds in wheat grain cultivars. Plant Food. Hum. Nutr. 2011, 66, 408-415.
39. Wiese, S., Esatbeyoglu, T., Winterhalter, P., Kruse, H. P. et al., Comparative biokinetics and metabolism of pure monomeric, dimeric and polymeric flavan-3-ols: a randomized cross-over study in humans. Mol. Nutr. Food Res. 2014, 59, 610-621.
40. Chirumbolo, S., Plant phytochemicals as new potential drugs for immune disorders and cancer therapy: really a promising path? J. Sci. Food Agr. 2012, 92, 1573-1577.
41. Chirumbolo, S., Marzotto, M., Conforti, A., Vella, A. et al., Bimodal action of the flavonoid quercetin on basophil function: an investigation of the putative biochemical targets. Clin. Mol. Allergy 2010, 8, 13-25.
42. Rodriguez-Mateos, A., Rendeiro, C., Bergillos-Meca, T., Tabatabaee, S. et al., Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am. J. Clin. Nutr. 2013, 98, 1179-1191.
43. Kay, C. D., Hooper, L., Kroon, P. A., Rimm, E. B. et al., Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products. Mol. Nutr. Food Res. 2012, 56, 1605-1616.
44. Harasstani, O. A., Moin, S., Tham, C. L., Liew, C. Y. et al., Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells. Inflamm. Res 2010, 59, 711-721.
45. Monagas, M., Khan, N., Andres-Lacueva, C., Urpi-Sarda, M. et al., Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Brit. J. Nutr. 2009, 102, 201-206.
46. Wei, M., Chu, X., Jiang, L., Yang, X. et al., Protocatechuic acid attenuates lipolysaccharide-induced acute lung injury. Inflammation 2012, 35, 1169-1178.
47. Chanput, W., Mes, J., Vreeburg, R. A., Savelkoul, H. F. et al., Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds. Food Funct. 2010, 1, 254-261.
48. Vogl, S., Atanasov, A. G., Binder, M., Bulusu, M. et al., The Herbal Drug Melampyrum pratense L. (Koch): isolation and identification of its bioactive compounds targeting mediators of inflammation. Evid. Based Complement. Alternat. Med 2013, 2013, 1-10.
49. Kim, M. S., Kim, S. H., Inhibitory effect of astragalin on expression of lipopolysaccharide-induced inflammatory mediators through NF-kappaB in macrophages. Arch. Pharmacal. Res. 2011, 34, 2101-2107.
50. Erlund, I., Freese, R., Marniemi, J., Hakala, P. et al., Bioavailability of quercetin from berries and the diet. Nutr. Cancer 2006, 54, 13-17.
51. Lee, W., Ku, S. K., Bae, J. S., Vascular barrier protective effects of orientin and isoorientin in LPS-induced inflammation in vitro and in vivo. Vasc. Pharmacol. 2014, 62, 3-14.
52. Ku, S. K., Lee, I. C., Han, M. S., Bae, J. S., Inhibitory effects of rutin on the endothelial protein C receptor shedding in vitro and in vivo. Inflammation 2014, 37, 1424-1431.
53. Catalan, U., Fernandez-Castillejo, S., Angles, N., Morello, J. R. et al., Inhibition of the transcription factor c-Jun by the MAPK family, and not the NF-kappaB pathway, suggests that peanut extract has anti-inflammatory properties. Mol. Immunol. 2012, 52, 125-132.
54. Hehlgans, T., Pfeffer, K., The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115, 1-20.
55. Black, R. A., Kronheim, S. R., Cantrell, M., Deeley, M. C. et al., Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 1988, 263, 9437-9442.
56. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. et al., Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29, 71-109.
57. Giambelluca, M. S., Cloutier, N., Rollet-Labelle, E., Boilard, E. et al., Expression and regulation of glycogen synthase kinase 3 in human neutrophils. Int. J. Biochem. Cell Biol. 2013, 45, 2660-2665.
58. Bak, M. J., Truong, V. L., Kang, H. S., Jun, M. et al., Anti-inflammatory effect of procyanidins from wild grape (Vitis amurensis) seeds in LPS-induced RAW 264.7 cells. Oxid. Med. Cell. Longev. 2013, 2013, 1-11.
59. Joo, S. Y., Song, Y. A., Park, Y. L., Myung, E. et al., Epigallocatechin-3-gallate inhibits LPS-induced NF-kappaB and MAPK signaling pathways in bone marrow-derived macrophages. Gut Liver 2012, 6, 188-196.
60. Ichikawa, D., Matsui, A., Imai, M., Sonoda, Y. et al., Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774.1. Biol. Pharmaceut. Bull. 2004, 27, 1353-1358.